e-Profile Login and ID Quick Search
Alaska News: Prescription Drug Monitoring Program Update
Originally published in the April 2011 Alaska Board of Pharmacy Newsletter
The current emphasis of the prescription drug monitoring program (PDMP) is the creation, initial orientation, and implementation of the PDMP Advisory Board. The Advisory Board is planned to include the program coordinator, a pharmacist Board member, a public member, and practitioners from the veterinary, dental, nursing, and medical boards. The Advisory Board will have input on PDMP policies, waivers, regulations, and decisions based on the perspective of their given profession. With assistance as needed, they will evaluate the significance of data generated by the PDMP and then make recommendations to the Board of Pharmacy based on these findings. After members are identified, an orientation to the role of the Advisory Board will be scheduled. The time commitment is likely to be slightly greater during the initial phase and level off over time. Licensees are encouraged to share this information with those who may be interested in participating in the PDMP Advisory Board.
The Alaska Board of Pharmacy homepage will continue to have current information about the status of the PDMP, a link to RelayHealth, and contact information.
